Published by Josh White on 3rd September 2025
(Sharecast News) - Shield Therapeutics reported a sharp rise in first-half revenue on Wednesday, as sales of its oral iron therapy Accrufer accelerated across key markets, leaving the company on track to reach cash flow breakeven by the end of 2025.
URL: http://www.digitallook.com/dl/news/story/35328512/...